Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 10, 2011 - Issue 4
Submit an article Journal homepage
353
Views
22
CrossRef citations to date
0
Altmetric
Reviews

Leflunomide-induced interstitial pneumonitis might be a representative of disease-modifying antirheumatic drug-induced lung injury

Shigeko InokumaDepartment of Allergy and Rheumatic Diseases, Rheumatology Center, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo 150-8935, Japan+81 3 3400 1311; +81 3 3409 1604/3400 0163; [email protected]
, MD
Pages 603-611 | Published online: 17 Mar 2011

Bibliography

  • Arava tablet 10 mg/20 mg/100 mg. Pharmaceuticals and Medical Devices Agency. Tokyo, 2010. Available from: http://www.info.pmda.go.jp/go/pack/3999020F1029_1_11/ [Last accessed August 2010]
  • Kamata Y, Nara H, Kamimura T, Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction. Intern Med 2004;43:1201-4
  • Takeishi M, Akiyama Y, Akiba H, Leflunomide induced acute interstitial pneumonia. J Rheumatol 2005;32:1160-3
  • Ochi S, Harigai M, Mizoguchi F, Leflunomide-related acute interstitial pneumonia in two patients with rheumatoid arthritis: autopsy findings with a mosaic pattern of acute and organizing diffuse alveolar damage. Mod Rheumatol 2006;16:316-20
  • Hirabayashi Y, Shimizu H, Kobayashi N, Kudo K. Leflunomide-induced pneumonitis in a patient with rheumatoid arthritis. Intern Med 2006;45:689-91
  • Otsuka T, Koyama T, Ohtani R, Leflunomide-induced lung injury that developed after its withdrawal, coinciding with peripheral blood lymphocyte count decrease. Mod Rheumatol 2008;18:96-9
  • Sawada T, Inokuma S, Sato T, Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis. Rheumatology (Oxford) 2009;48:1069-72
  • Vallbracht I, Popper HH, Rieber JF, Lethal pneumonitis under leflunomide therapy. Rheumatology 2005;44:1580-1
  • Hashimoto K, Nakanishi H, Yamasaki A, Pulmonary findings without the influence of therapy in a patient with rheumatoid arthritis: an autopsy case. J Med Invest 2007;54:340-4
  • Tansey D, Wells AU, Colby TV, Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004;44:585-96
  • Saravanan V, Kelly CA. Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis. Rheumatology (Oxford) 2004;43:143-7
  • Sato T, Inokuma S, Sagawa A, Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis. Rheumatology (Oxford) 2009;48:1265-8
  • Inokuma S, Sato T, Sagawa A, Proposals for leflunomide use to avoid lung injury in patients with rheumatoid arthritis. Mod Rheumatol 2008;18:442-6
  • Chikura B, Lane S, Dawson JK. Clinical expression of leflunomide-induced pneumonitis. Rheumatology 2009;48:1065-8
  • Savage RL, Highton J, Boyd IW, Chapman P. Pneumonitis associated with leflunomide: a profile of New Zealand and Australian reports. Intern Med J 2006;36:162-9
  • Suissa S, Hudson M, Ernst P. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis. Arthritis Rheum 2006;54:1435-9
  • Ju J, Kim Sl, Lee J, Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis. Arthritis Rheum 2007;56:2094-6
  • Balakrishnan C, Dasgupta B. Pulmonary adverse events with leflunomide–myth or reality? Rheumatology (Oxford) 2007;46:372
  • Saravanan V, Kelly C. Drug-related pulmonary problems in patients with rheumatoid arthritis. Rheumatology 2006;45:787-9
  • Wong SP, Chu CM, Kan CH, Successful treatment of leflunomide-induced acute pneumonitis with cholestyramine wash-out therapy. J Clin Rheumatol 2009;15(8):389-92
  • Miwa Y, Isozaki T, Wakabayashi K, Tacrolimus-induced lung injury in a rheumatoid arthritis patient with interstitial pneumonitis. Mod Rheumatol 2008;18:208-11
  • Tacrolimus hydrate capsule 0.5 mg/1 mg. Pharmaceuticals and Medical Devices Safety Information No. 231. Available from: http://www.mhlw.go.jp/houdou/2006/12/h1221-4.html [Last accessed December 2006]
  • Inokuma S, Kono H, Kohno Y, Methotrexate-induced lung injury in patients with rheumatoid arthritis occurs with peripheral blood lymphocyte count decrease. Ann Rheum Dis 2006;65:1113-14
  • The Study Committee for Leflunomide-induced Lung Injury, the Japan College of Rheumatology. Lung injury under the use of leflunomide. 22nd Annual Meeting of Kanto Area of the Japan College of Rheumatology; Tokyo; 2007
  • Nakagawa M, Nishimura T, Teramukai S, Interstitial lung disease in gefitinib-treated Japanese patients with non-small cell lung cancer – a retrospective analysis: JMTO LC03-02. BMC Res Notes 2009;2:157

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.